Trial
NCT00513188
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Miami
Collaborators
—
Condition
Lymphoma
Intervention
denileukin diftitox
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-15